American Academy of Addiction Psychiatry 23-27th Annual Meeting and Symposium
美国成瘾精神病学学会第 23-27 届年会暨研讨会
基本信息
- 批准号:8862437
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-20 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAdvertisementsAmericanAreaAwardBasic ScienceCaringChargeClinicalClinical ResearchClinical Trials NetworkCommunitiesCriminal JusticeDataDiagnosisDisadvantagedDrug abuseE-learningEducational workshopEnsureEvidence based treatmentFertilizationFosteringFundingFutureGrantGuidelinesHealth PersonnelHealth ProfessionalIndividualInformation DisseminationInternational AspectsJunior PhysicianMedicalMental disordersMentorsMinorityNational Institute of Drug AbuseNatureParticipantPhysiciansPlayPoliciesPositioning AttributePsychiatristPsychiatryPublic HealthPublicationsResearchResearch PersonnelResearch Project GrantsRoleScienceStrategic PlanningSubstance Use DisorderSystemTimeTrainingTraining and EducationTravelUpdateWorkaddictionbasecareerclinical practicecombatdesignevidence baseexperienceimprovedinnovationmeetingsoutreachplanetary Atmosphereposterssymposiumtreatment planningworking group
项目摘要
DESCRIPTION (provided by applicant): The American Academy of Addiction Psychiatry's (AAAP) Annual Scientific Meeting and Symposium provides a unique forum for disseminating state-of-the-art information to physicians and other health professionals in the field of substance
use disorders and co-occurring medical and psychiatric disorders. AAAP's educational objectives are to: 1) Train clinicians to identify and diagnose substance use disorders and apply evidence-based approaches, and 2) Help clinicians competently develop treatment plans for individuals with substance use disorders, including those with co-occurring mental disorders, using established treatment guidelines. With over 425 participants in attendance over the past few years the meeting provides an ideal setting for networking, mentoring and cultivating collaborative efforts. The meeting is designed to present the latest findings from basic and clinical research as well as innovations in training and education in the field of addictions. Whil a focal point of the meeting is dissemination of information through a variety of mechanisms (symposia, workshops, case conferences, etc.), the meeting also provides the organizational backdrop for the exchange of ideas, discussions and working groups focused on other AAAP educational, training and policy- based activities. For the past 10 years, AAAP has received support from NIDA for this meeting which has been critical to improving and expanding the meeting including: 1) conference proceedings provided on CD-ROMs for all participants at no charge, to be used as references for establishing clinical practice and promoting research, 2) Support for trainees to attend the annual meeting which plays a critical role in engaging early career physicians to the field, and 3) supporting a NIDA Clinical Trials Network (CTN) symposium highlighting CTN projects that are most ready for dissemination to influence clinical practice. In particular, AAAP's CTN Symposium has been a well-attended and an important part of the Annual Meeting and we plan on continuing an annual CTN update in the future should this application be funded. . Also described in this application are plans for other symposia, workshops, and mentoring activities that will be part of the Annual Meetings during the period of support requested. AAAP's Annual Meeting and Symposia have benefited greatly from ongoing NIDA support. We hope to continue to work together with NIDA to provide state-of-the-art information about evidence-based treatments to growing number of physicians and other health-care providers who are addiction clinicians, research and educators.
描述(由申请者提供):美国成瘾精神病学学会(AAAP)年度科学会议和研讨会为在物质领域向医生和其他健康专业人员传播最先进的信息提供了一个独特的论坛
使用障碍和共生的内科和精神障碍。AAAP的教育目标是:1)培训临床医生识别和诊断药物使用障碍并应用循证方法,2)帮助临床医生使用既定的治疗指南,有能力地为药物使用障碍患者制定治疗计划,包括那些精神障碍患者。在过去的几年里,有超过425人参加了这次会议,会议为建立网络、指导和培养合作努力提供了一个理想的环境。这次会议旨在介绍基础和临床研究的最新发现,以及成瘾领域培训和教育方面的创新。虽然会议的焦点是通过各种机制(专题讨论会、讲习班、个案会议等)传播信息,但会议也为交流想法、讨论和工作组提供了组织背景,重点放在其他AAAP教育、培训和基于政策的活动上。在过去的10年里,AAAP在这次会议上得到了NIDA的支持,这对改进和扩大会议至关重要,包括:1)为所有与会者免费提供会议记录光盘,作为建立临床实践和促进研究的参考,2)支持学员参加年度会议,该会议在吸引早期职业医生进入该领域方面发挥了关键作用,以及3)支持NIDA临床试验网络(CTN)研讨会,突出最准备传播影响临床实践的CTN项目。特别是,AAAP的CTN研讨会一直是年会的一个重要组成部分,出席人数很多,我们计划在未来继续每年更新CTN,如果这项申请得到资助的话。。本申请中还描述了其他研讨会、研讨会和指导活动的计划,这些活动将在请求的支持期间作为年会的一部分。AAAP的年会和研讨会从NIDA的持续支持中受益匪浅。我们希望继续与NIDA合作,为越来越多的医生和其他医疗保健提供者提供关于循证治疗的最新信息,他们是成瘾临床医生、研究和教育工作者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frances Rudnick Levin其他文献
Frances Rudnick Levin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frances Rudnick Levin', 18)}}的其他基金
Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder
利用内侧前额叶和前扣带皮层的 rTMS 增强认知行为疗法治疗可卡因使用障碍
- 批准号:
10681981 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
开发 PPL-138,一种用于治疗可卡因使用障碍的新型混合 NOP/Mu 部分激动剂
- 批准号:
10707176 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
开发 PPL-138,一种用于治疗可卡因使用障碍的新型混合 NOP/Mu 部分激动剂
- 批准号:
10616932 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies
AEF0117 作为大麻使用障碍潜在治疗方法的进展:临床前毒性和临床药代动力学研究
- 批准号:
10668477 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
The CB1 Signaling-Specific Inhibitor, AEF0117, for Cannabis Use Disorder: A Multi-Site Treatment Trial
CB1 信号传导特异性抑制剂 AEF0117,用于治疗大麻使用障碍:多部位治疗试验
- 批准号:
10249716 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues
使用芬太尼类似物缓释丁丙诺啡与舌下含服丁丙诺啡治疗阿片类药物使用障碍患者的随机对照试验
- 批准号:
9979016 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues
使用芬太尼类似物缓释丁丙诺啡与舌下含服丁丙诺啡治疗阿片类药物使用障碍患者的随机对照试验
- 批准号:
10158460 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders
大麻素的共同药物治疗策略
- 批准号:
9098672 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders
大麻素的共同药物治疗策略
- 批准号:
8742325 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 2.5万 - 项目类别:
Research Grant














{{item.name}}会员




